February 12, 2017

Ceapro Inc. a small biotechnology company that trades on the Venture exchange is added to the list as a Speculative Buy. It’s not easy to get a good understanding of a company like Ceapro given that it is very research and science based. I have tried to gain a reasonable understanding of it and to convey that in my report. I intend to buy some shares. But I consider this to be speculative and will not be investing a large dollar amount. I am going to take an initial small position and I will likely be prepared to double that if the price happens to drop substantially. Subscribers should read the report closely given the more speculative nature of this investment.

Scroll to Top